BioSpace News Archive

Business

Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors

Ochre Bio, an innovator in chronic liver disease medicine development, announced the appointment of Eliot Forster, Ph.D. as Chairperson of the Board of Directors.

May 16, 2023
·
3 min read
Biotech Beach

iXCells Biotechnologies Expands CRISPR-Cas9 Cell Products and Genome Engineering Services

iXCells Biotechnologies, a provider of cell products and drug discovery services to the worldwide academic, biotech and pharmaceutical communities, announced expansion of its CRISPR-Cas9 product and custom services offering, with special focus on induced pluripotent stem cell derived cell models.

May 16, 2023
·
3 min read
Drug Development

AOBiome announces the publication of positive Phase 2b results in The Lancet’s eClinicalMedicine for B244 in the treatment of mild-to-moderate atopic dermatitis and moderate-to-severe pruritus

AOBiome Therapeutics, Inc. (“AOBiome”) today announces that The Lancet’s eClinicalMedicine, a peer-reviewed medical journal, has published a report describing the Company’s Phase 2b clinical data for its B244 treatment for mild-to-moderate atopic dermatitis and moderate-to-severe pruritus.

May 16, 2023
·
4 min read
At 6.6% CAGR, Pharmaceutical Excipients Market Revenue to Cross $12.24 Billion, Globally by 2028 | The Insight Partners

The Insight Partners published latest research report on “Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Clinical Indication, Functionality, Application, End User”,

May 16, 2023
·
8 min read
High Throughput Screening Market Growth to Hit 8.5% CAGR during (2021-2028) | Driven by Use of AI in HTS

The Insight Partners published latest research report on “High Throughput Screening Market Revenue Report, Trends, Growth & Demand Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service, Technology, Application, End User”

May 16, 2023
·
6 min read
Business

3M and Svante Announce Joint Development Agreement to Develop and Produce CO2 Removal Products

3M is expanding its ongoing commitment to materials science-based climate tech solutions by working with BC-based Svante Technologies, Inc. to develop material that can trap carbon dioxide found in the atmosphere and permanently remove it.

May 16, 2023
·
3 min read
Policy

FDA Roundup: May 16, 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

May 16, 2023
·
2 min read
Business

Constitution Surgery Alliance (CSA) Appoints Rod Carbonell as Chief Development Officer

Constitution Surgery Alliance, a leading operator of outpatient surgery centers, is pleased to announce the appointment of Rod Carbonell, RN, BSN, MHA to the role of Chief Development Officer.

May 16, 2023
·
2 min read
Biotech Bay

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - May 16, 2023

Annexon, Inc. announced that it has granted equity inducement awards to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan.

May 16, 2023
·
1 min read
Drug Development

X4 Pharmaceuticals Announces Positive Phase 3 Results Showing Mavorixafor Reduced the Rate, Severity, and Duration of Infections vs. Placebo in Participants Diagnosed with WHIM Syndrome

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR) is hosting a webinar today highlighting new data from its global, pivotal, 4WHIM Phase 3 clinical trial of once-daily, oral mavorixafor in individuals with WHIM syndrome.

May 16, 2023
·
10 min read